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PCR fingerprinting was used to characterize clinical isolates of Mycoplasma pneumoniae. Among 24 strains
tested, two types were distinguished. Nineteen strains belonged to type 1, whereas only 5 strains belonged to
type 2. The majority of strains isolated since 1991 in Belgium belong to type 1. No variations in fingerprinting
patterns were observed within each group, confirming the highly conserved nature of the M. pneumoniae genome.
Mycoplasma pneumoniae is an important respiratory tract
pathogen. It is a leading cause of atypical pneumonia and other
respiratory infections such as tracheobronchitis, bronchiolitis,
croup, and less severe upper respiratory tract infections (8).
The incidence rate varies greatly according to age and is
highest among primary school children. Epidemics take place
at intervals of 4 to 7 years (5). M. pneumoniae infections spread
slowly in the family setting, with a median case-to-case interval
of 23 days (4).
A 170-kDa protein, P1, has been identified as a major
cytadhesin and virulence factor of M. pneumoniae (2). This
protein and the gene coding for it have been extensively
studied. On the basis of hybridization patterns with subclones
of the P1 gene as probes in Southern blot analysis of genomic
DNA (12), clinical isolates of M. pneumoniae can be classified
into two types. Sequence analysis of the P1 gene revealed
sequence divergence between isolates belonging to the two
different types (10). This classification into two types was
confirmed by restriction enzyme fingerprinting of genomic
DNA and two-dimensional gel electrophoresis of total proteins
(11). We report here on the use of a DNA amplification
fingerprinting technique (16) for typing a collection of 24
isolates of M. pneumoniae.
The M. pneumoniae strains analyzed in this study are listed
in Table 1. Fifteen M. pneumoniae strains were isolated from
clinical samples in Antwerp, Belgium, in the course of a study
of respiratory tract infections in children during two winter
periods (from 1 October 1991 to 31 March 1992 and from 1
October 1992 to 31 March 1993) (6). In this study, nasopha-
ryngeal aspirates of pediatric patients were analyzed for the
presence of M. pneumoniae and respiratory viruses. The pres-
ence of M. pneumoniae was detected by culture and by a PCR
that amplifies part of the P1 gene (15). The fifteen strains were
isolated from 15 outpatients epidemiologically not related to
each other. Besides the strains isolated in Belgium, nine other
strains were analyzed: three strains isolated in the United
Kingdom between 1983 and 1986 (M 15/83, M 414/86, and M
510/86) and three strains isolated in The Netherlands between
1970 and 1987 (P 635, P 71, and P 84). Finally, three M.
pneumoniae reference strains were included in the study (FH,
MAC, and PI 1428).
For cultivation, a 0.2-ml aliquot of nasopharyngeal aspirate
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was inoculated into 2 ml of SP4 broth (14) without thallium
acetate and supplemented with amphotericin B (0.5 mg/ml)
and polymyxin B (500 U/ml). Three serial 20-fold dilutions of
this primary broth were made in SP4 broth. The four broths
were incubated aerobically at 37°C and observed for color
change over a period of 6 weeks. When color change was
noticed, a 0.1-ml aliquot of the broth was subcultured on an
SP4 solid medium (made by adding 8 g of agar per liter). The
SP4 agar was examined weekly for the appearance of typical M.
pneumoniae colonies, which were then subcultured in fresh
SP4 broth for subsequent DNA extraction.
Lyophilized M. pneumoniae strains that were sent to our
laboratory were cultivated accordingly.
For DNA extraction, 200 ,ul of culture was centrifuged at
13,000 x g for 40 min at room temperature. Pellets were
resuspended in 150 RI of buffer containing 50 mM glucose, 25
mM Tris HCl (pH 8), and 10 mM EDTA and lysed after
addition of 12.5 RI (1 mg/ml) of proteinase K and 12.5 RI of
10% (wt/vol) sodium dodecyl sulfate. Incubation took place at
50°C for 30 min. DNA was isolated by subsequent phenol and
phenol-chloroform-isoamyl alcohol (25:24:1) extractions fol-
lowed by ethanol precipitation (9). DNA concentrations were
estimated by gel electrophoresis through 1% agarose gels in
0.09 M Tris borate-0.002 M EDTA, staining with ethidium
bromide, and comparison with samples containing a known
amount of DNA (9).
For PCR fingerprinting, several primers were tested. A list
of the primers used is presented in Table 2. For amplification,
the reaction mixtures consisted of 10 mM Tris HCl (pH 9), 50
mM KCl, 2.5 mM MgCl2, 0.1% Triton X-100, and 0.2 mM
deoxynucleoside triphosphates. One unit of Taq DNA poly-
merase (Shaero-Q, Leiden, The Netherlands), 50 pmol of
primers, and about 10 ng of DNA were used in a final reaction
volume of 100 pI. The amplification time and temperature
profiles that were used for primers HLW 74, HLW 85, 1254, D
14216, and D 8635 were as described previously (1, 7). With
primer OJPU4, the first four cycles consisted of 5 min of
denaturation at 94°C, 5 min of hybridization at 36°C, and 5 min
of elongation at 72°C. For the 30 cycles that followed, the
denaturation and hybridization times were reduced to 1 min,
whereas the elongation time was reduced to 2 min. The final
elongation step was 10 min. Amplifications were carried out in
a Biomed model 60 thermocycler or a Techne model PHC-2
thermocycler. The amplification products were size fractionated
on a 1% agarose gel containing 0.09 M Tris borate and 0.002 M
EDTA and visualized by staining with ethidium bromide (9).












TABLE 1. M. pneumoniae strains used in the study
Strain Source Yr and source of Clinical picture Typebisolation
FH (NCTC 10119) NCTC 1959; not specified Pneumonia 2
M 15/83 NCTC 1983; sputum Pneumonia 1
M414/86 NCTC 1986; sputum Pneumonia 1
M510/86 NCTC 1986; sputum Pneumonia 1
P635 RIVM 1970's; throat swab Pneumonia 2
P71 RIVM 1987; BALC Pneumonia 1
P84 RIVM 1973; not specified Pneumonia 2
M2117350 UZA 1992; NPAd Acute bronchitis 1
M2107084 UZA 1992; throat swab Acute bronchitis 1
Erythema multiforma
M2117245 UZA 1992; NPA URTI" 1
M2107079 UZA 1992; sputum Acute lobar pneumonia 1
M2107374 UZA 1992; NPA Acute lobar pneumonia 1
M2117235 UZA 1992; throat swab Acute lobar pneumonia 1
M2117430 UZA 1992; NPA Acute bronchitis 1
M3057031 UZA 1993; NPA Acute bronchitis 1
M3037439 UZA 1993; NPA Acute bronchopneumonia 1
21C86 UZA 1992; NPA Acute bronchitis 1
21K11 UZA 1992; NPA Acute bronchopneumonia 2
21K33 UZA 1992; NPA Acute bronchopneumonia 1
21G93 UZA 1992; NPA Acute bronchopneumonia 1
21I105 UZA 1992; sputum Acute bronchopneumonia 1
Exanthema
DEV UZA 1991; NPA Acute bronchopneumonia 1
Erythema multiforma
PI1428 (ATCC 29085) ATCC 1964; throat swab Pneumonia 1
MAC (ATCC 15492) ATCC 1944; lung tissue Not specified 2
a Abbreviations: NCTC, National Collection of Type Cultures, Central Public Health Laboratory, London, United Kingdom; ATCC, American Type Culture
Collection, Rockville, Md.; RIVM, Rijksinstituut voor Volksgezondheid en Milieuhygiene, Bilthoven, The Netherlands; UZA, Universitair Ziekenhuis Antwerpen,
Edegem, Belgium.
b Typing results were obtained with PCR fingerprinting as described in this study.
BAL, bronchoalveolar lavage.
d NPA, nasopharyngeal aspirate.
URTI, upper respiratory tract infection.
were used to amplify DNA from 15 M pneumoniae strains
chosen randomly from the collection of strains listed in Table
1. One primer (D 8635) produced the same pattern for all
strains examined. With the other primers, two patterns could
be observed, the difference being most pronounced with
primers OJPU4 and 1254.
In a second series of experiments, primer OJPU4 was used
to amplify DNA from the 24 M pneumoniae strains of the
collection. Primer 1254 was used to confirm the results ob-
tained with OJPU4.
Our collection of strains could be divided into two types on
the basis of their PCR fingerprinting patterns with OJPU4 and
1254. The majority of strains (19 of 24) belonged to type 1.
Only five strains were classified as type 2 because they showed
a different pattern with both primers: strains MAC, FH, P 84,
P 635, and 21K11. Fingerprinting patterns of representatives of
the two groups with primers 1254 and OJPU4 are shown in Fig.
1. The results obtained with the PCR fingerprinting were
reproducible from one run to another, except for differences in
band intensities that were therefore not taken into consideration.
Moreover, the method is fairly rapid, because amplification and
separation of amplification products can be performed in 1 day.
Our results confirm the existence of only two types among
clinical isolates ofM pneumoniae strains, as was demonstrated
by other typing methods (10-12). Within each type, no varia-
tions in DNA or protein fingerprinting profiles were observed
(11). These and our findings indicate thatM pneumoniae as a
species has preserved overall genetic homology. Diversity of a
species reflects evolutionary genetic divergence arising from
random, nonlethal mutations that accumulate over time. M
pneumoniae has one of the smallest genomes of known self-
replicating organisms, about 809 kb (17). Selective pressure
TABLE 2. DNA primers used for PCR-mediated genetic typing of M. pneumoniae isolates
Primer Primer sequence Primer type Referencenumber
HLW 74 5' ACGTATCTGC 3' Arbitrary 7
HLW 85 5' ACAACTG-CTC 3' Arbitrary 7
1254 5' CCGCAGCCAA 3' Arbitrary 1
D14216 5' NNNAACAGCTATGACCATG 3' Arbitrary 1
D8635 5' GAGCGGCCAAAGGGAGCAGAC 3' Arbitrary 1
OJPU4 5' GGCCATGACCGCGAACTATCCG 3' P1 gene sequence (nt 1191-1212)a This study













FIG. 1. PCR-mediated DNA typing of M. pneumoniae strains.
Banding patterns obtained with M. pneumoniae strains with primer
1254 (A) and with primer OJPU4 (B) are shown. Lanes: 1 to 3, M.
pneumoniae type 1 strains; 4 to 6, M. pneumoniae type 2 strains; M,
molecular weight marker (pBR328-BglI and Hinfl fragments) (Boehr-
inger Mannheim, Mannheim, Germany).
may be too high in M. pneumoniae because of the small size of
its genome, preventing diversity of the species. Clearly, the M.
pneumoniae population structure is highly clonal. Of course, it
cannot be excluded that by performing PCR fingerprinting
with other arbitrary primers or by performing sequence anal-
ysis of unknown regions of the genome, additional differences
between isolates belonging to the same type will be found.
In the study by Su et al. (12), 29 M. pneumoniae strains were
included, collected from different geographic areas (California,
North and South Carolina, Texas, Washington, and France)
and at different times (from 1944 to 1988). On the basis of
genotyping, they found only 4 strains that belonged to type 1
out of 29 tested, whereas the great majority of their strains
belonged to type 2 (25 of 29). This is in sharp contrast to our
findings, since we found only 5 strains belonging to type 2 out
of 24 tested. Our classification of type 2 strains is based on the
type found for the reference strains FH and MAC that were
classified by Su et al. (12) as type 2. The reference strain PI
1428 that we used in this study was classified by Chandler et al.
(3) in the same group as strain M 129, which is classified as a
type 1 strain in the study of Su et al. (12), whereas Chandler et al.
also classified strains FH and MAC as type 2 in their genotypic
study. Therefore, the majority of strains that were isolated in
Belgium during the last 2 years belong to Su et al.'s (12) type 1
classification.
Apparently, two types of M. pneumoniae strains are encoun-
tered worldwide. Interestingly, the prevalence of each type
seems to be related by time and geography. In the 1970s and
1980s, the majority of strains isolated in the United States and
France were type 2 strains. However, the three strains isolated
in the 1980s in the United Kingdom were type 1 strains. The
majority of strains that have been found since 1991 in Belgium
are type 1 strains. Maybe this switch in prevalent type can be
explained by the immune status of the population against one
type or another.
Another interesting point is whether the type of strain can be
associated with the clinical picture of the patient. In this study,
we could not find a relationship between the type of strain and
the severity of the disease (Table 1). The majority of patients
had pneumonia or bronchitis. Only one patient had an upper
respiratory tract infection. This strain could not be distin-
guished from the others on the basis of the fingerprinting pattern.
We conclude that PCR fingerprinting is a rapid and reliable
method for typing M. pneumoniae isolates. There is an excel-
lent correlation with results obtained with other molecular
typing methods. M pneumoniae isolates can be divided into
two types. The method could not distinguish isolates within
each group, confirming the highly conserved nature of the M
pneumoniae genome and clonality of the population structure.
We thank J. Tully for providing us with very helpful information for
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strains, R. Leach from the NCTC and A. Angulo from the RIVM for
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reading of the manuscript and helpful comments, and Edwin Fries for
technical assistance.
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